Cell-mediated immune responses (CMIR) in human rhinosporidiosis.
Cell mediated immune responses (CMIR) to Rhinosporidium seeberi in human patients with rhinosporidiosis have been studied. With immuno-histochemistry, the cell infiltration patterns in rhinosporidial tissues from 7 patients were similar. The mixed cell infiltrate consisted of many plasma cells, fewer CD68+ macrophages, a population of CD3+ T lymphocytes, and CD56/57+ NK lymphocytes which were positive for CD3 as well. CD4+ T helper cells were scarce. CD8+ suppressor/cytotoxic-cytolytic cells were numerous. Most of the CD8+ cells were TIA1+ and therefore of the cytotoxic subtype. CD8+ T cells were not sub-typed according to their cytokine profile; 1L2, IFN-gamma (Tcl); IL4, ILS (Tc2). In lympho-proliferative response (LPR) assays in vitro, lymphocytes from rhinosporidial patients showed stimulatory responses to Con A but lymphocytes from some patients showed significantly diminished responses to rhinosporidial extracts as compared with unstimulated cells or cells stimulated by Con A, indicating suppressor immune responses in rhinosporidiosis. The overall stimulatory responses with Con A suggested that the rhinosporidial lymphocytes were not non-specifically anergic although comparisons of depressed LPR of rhinosporidial lymphocytes from individual patients, to rhinosporidial antigen with those to Con A, did not reveal a clear indication as to whether the depression was antigen specific or non-specific. The intensity of depression of the LPR in rhinosporidial patients bore no relation to the site, duration, or the number of lesions or whether the disease was localized or disseminated. Rhinosporidial extracts showed stimulatory activity on normal control lymphocytes, perhaps indicating mitogenic activity. These results indicate that CMIR develops in human rhinosporidiosis, while suppressed responses are also induced.
de Silva
N R
NR
Medical Research Institute, Colombo, Sri Lanka.
Huegel
H
H
Atapattu
D N
DN
Arseculeratne
S N
SN
Kumarasiri
R
R
Gunawardena
S
S
Balasooriya
P
P
Fernando
R
R
D000942:Antigens, Bacterial / Q000276:immunology; D003208:Concanavalin A / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007150:Immunohistochemistry; D008213:Lymphocyte Activation / Q000276:immunology; D009298:Nasal Polyps / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D012140:Respiratory Tract Diseases / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D012227:Rhinosporidiosis / Q000276:immunology* / Q000382:microbiology / Q000473:pathology; D012228:Rhinosporidium / Q000276:immunology*; D012882:Skin Tests
D000942:Antigens, Bacterial; D003208:Concanavalin A